120 related articles for article (PubMed ID: 19024387)
1. [CYP2D6*10 polymorphisms and lung cancer susceptibility].
Yan Z; Wu YM; Wu YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):564-8. PubMed ID: 19024387
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes.
Huang J; Chuang SK; Cheng CL; Lai ML
Clin Pharmacol Ther; 1999 Apr; 65(4):402-7. PubMed ID: 10223777
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6.
Wang SL; Huang JD; Lai MD; Liu BH; Lai ML
Clin Pharmacol Ther; 1993 Apr; 53(4):410-8. PubMed ID: 8097442
[TBL] [Abstract][Full Text] [Related]
4. Influence of CYP2D6 and β2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.
Zhang F; Duan X; Zhang M; Li Z; He Q; Wang Y; Miao C; Zhong W; Zou X; Zhuge Y
J Gastroenterol Hepatol; 2016 Apr; 31(4):829-34. PubMed ID: 26489037
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4502D6 (debrisoquine 4-hydroxylase) and Parkinson's disease in Chinese and Caucasians.
Ho SL; Kung MH; Li LS; Lauder IJ; Ramsden DB
Eur J Neurol; 1999 May; 6(3):323-9. PubMed ID: 10210913
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships.
Laforest L; Wikman H; Benhamou S; Saarikoski ST; Bouchardy C; Hirvonen A; Dayer P; Husgafvel-Pursiainen K
Eur J Cancer; 2000 Sep; 36(14):1825-32. PubMed ID: 10974631
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.
Gao Y; Zhang Q
Mutat Res; 1999 Aug; 444(2):441-9. PubMed ID: 10521684
[TBL] [Abstract][Full Text] [Related]
8. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancer.
Su WM; Chen ZH; Zhang XC; Su J; Xie Z; Yan HH; Yang JJ; Chen HJ; Zhou Q; Zhong WZ; Guo WB; Chen SL; Wu YL
Int J Biol Markers; 2015 Jul; 30(3):e286-93. PubMed ID: 25744365
[TBL] [Abstract][Full Text] [Related]
10. G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese.
Wang SL; Lai MD; Huang JD
Drug Metab Dispos; 1999 Mar; 27(3):385-8. PubMed ID: 10064570
[TBL] [Abstract][Full Text] [Related]
11. [Human chromosome 8p11 (CHRNB3-CHRNA6) region gene polymorphisms and susceptibility to lung cancer in Chinese Han population].
Zhang XB; Zhao ZH; Chen HY; Wang JC; Qian J; Yang YJ; Wei QY; Huang J; Lu DR
Yi Chuan; 2011 Aug; 33(8):886-94. PubMed ID: 21831805
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer.
Chuang CL; Wang CH; Hsu CH; Hsiao CL; Chen GL; Yen ST; Li HT; Chang WS; Tsai CW; Wang SC; Bau DT
Anticancer Res; 2017 May; 37(5):2417-2423. PubMed ID: 28476809
[TBL] [Abstract][Full Text] [Related]
13. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
[TBL] [Abstract][Full Text] [Related]
14. [CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility].
Gao J; Ren C; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):185-6. PubMed ID: 10921002
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
17. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.
Liu Y; Bi Y; Lin J; Cao L; He B; Zhang Z; Cui Y; Zhang X
Tumour Biol; 2015 Mar; 36(3):1955-62. PubMed ID: 25394898
[TBL] [Abstract][Full Text] [Related]
18. Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes.
Tseng CY; Wang SL; Lai MD; Lai ML; Huang JD
Clin Pharmacol Ther; 1996 Aug; 60(2):177-82. PubMed ID: 8823235
[TBL] [Abstract][Full Text] [Related]
19. RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.
Xu XL; Zheng J; Mao WM; Ling ZQ
Cancer Med; 2016 Aug; 5(8):2084-90. PubMed ID: 27335251
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.
Legrand-Andréoletti M; Stücker I; Marez D; Galais P; Cosme J; Sabbagh N; Spire C; Cenée S; Lafitte JJ; Beaune P; Broly F
Pharmacogenetics; 1998 Feb; 8(1):7-14. PubMed ID: 9511176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
